1. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: A systematic review and meta-analysis
- Author
-
Muka, T. (Taulant), Oliver-Williams, C. (Clare), Colpani, V. (Veronica), Kunutsor, S. (Setor), Chowdhury, S. (Susmita), Chowdhury, R. (Rajiv), Kavousi, M. (Maryam), Franco, O.H. (Oscar), Muka, T. (Taulant), Oliver-Williams, C. (Clare), Colpani, V. (Veronica), Kunutsor, S. (Setor), Chowdhury, S. (Susmita), Chowdhury, R. (Rajiv), Kavousi, M. (Maryam), and Franco, O.H. (Oscar)
- Abstract
Importance Vasomotor symptoms (hot flushes and night sweats) and other symptoms, including depression, anxiety and panic attacks, are commonly experienced by menopausal women and have been associated with an unfavourable cardiovascular risk profile. Objective To investigate whether presence of menopausal symptoms is associated with the development of cardiovascular disease (CVD). Methods Five electronic databases (Medline, EMBASE and Web of Science) were search until February 17th, 2015 to identify relevant studies. Observational cohort studies or randomised intervention studies were eligible for inclusion if they followed participants prospectively (at least 1 year of follow-up), and reported relevant estimates on the association of any vasomotor symptoms, or other menopausal symptoms, with risk of CVD, coronary heart disease (CHD), or stroke in perimenopausal, menopausal, or postmenopausal women. Data were extracted by two independent reviewers using a pre-designed data collection form. Separate pooled relative risks (RRs) for age and non-established cardiovascular risk factors (e.g., education, ethnicity) adjusted data and for established cardiovascular risk factors and potential mediators-adjusted data (e.g., smoking, body mass index, and hypertension) were calculated. Results Out of 9,987 initially identified references, ten studies were selected, including 213,976 women with a total of 10,037 cardiovascular disease outcomes. The age and non-established cardiovascular risk factors adjusted RRs) [95% confidence intervals] for development of CHD, Stroke and CVD comparing women with and without any menopausal symptoms were 1.34 [1.13-1.58], 1.30 [0.99-1.70], 1.48 [1.21-1.80] respectively, and the corresponding RRs adjusted for cardiovascular risk factors and potential mediators were 1.18 [1.03-1.35], 1.08 [0.89-1.32], 1.29 [0.98-1.71]. However, these analyses were limited by potential unmeasured confounding and the small number of studies on this topic. Conclusion
- Published
- 2016
- Full Text
- View/download PDF